Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
10.1038/s41598-017-13601-y Sci
[39] defined treatment (exenatide, lixisenatide, semaglutide, dulaglutide, liraglutide, tirzepatide, albiglutide) and control groups based on GLP-1 RA exposure: the treatment group included patients who initiated a GLP-1 RA within 6 months of IIH diagnosis, while the control group consisted of patients who never initiated a GLP-1 RA but were managed with conventional therapies such as acetazolamide, topiramate and furosemide
Gastrointestinal side effects like nausea, vomiting, or diarrhea are common but often improve with proper titration
It is a mild, non-hormonal mechanism, not comparable in potency to finasteride or dutasteride, but carries none of their hormonal side effects
GHK-Cu can compete with these pathological proteins for copper binding, potentially reducing their toxicity while delivering bioavailable copper to neurons that require it for normal function
